HealthEXCLUSIVE: India orders Sun Pharma to halt eye-drug production at plant over quality failures
Indian drug regulators ordered Sun Pharmaceutical Industries to stop making, selling and distributing ophthalmic products from its Assam facility after identifying failures in its quality management system, documents reviewed by Reuters showed.
R
Reuters★★★☆☆2026-10-30 10:15Original
EXCLUSIVE: India orders Sun Pharma to halt eye-drug production at plant over quality failures
Health